{"text_format":"3","workbook":"xlsx","n_sheets":3,"sheets":["Unit requirement","Treatment Planning System","Applicators"],"not_rendered":{"images":1},"read":"whole","date_system":"1900"}

{"sheet":"Unit requirement","index":0,"n_rows":112,"n_cols":6,"rows_kept":112,"merged":[[0,0,0,5],[1,0,1,5],[2,0,2,5],[3,0,3,5],[4,0,4,5],[5,0,5,5],[6,0,6,5],[7,0,7,5],[8,0,8,5],[9,0,9,5],[10,0,10,5],[11,0,11,5],[12,0,12,5],[13,0,13,5],[14,0,14,5],[41,0,42,0],[111,0,111,1]]}
["                            ANNEXURE-A: PRODUCT SPECIFICATION"]
["THE SUPPLY, DELIVERY, INSTALLATION, COMMISSIONING AND MAINTENANCE OF  HIGH DOSE RATE (HDR) BRACHYTHERAPY UNIT AT GAUTENG HEALTH INSTITUTIONS FOR A PERIOD ON THREE YEARS"]
["Note:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   "]
["1. Technical Compliance"]
["The equipment offered must be technically compliant with all mandatory specifications and meet the minimum threshold to qualify for consideration for the next phase of evaluation."]
["2. Scoring of the bids"]
["2a. Weight: Each specification will have a weight of 1 or a hash (#), which indicates the level of importance, as follows:   "]
["1 -  A specification with a standard level of importance that must be complied with."]
["# -  Indicates a specification with a essential level of importance, where the bid offer will be disqualified, if the specification is not complied with."]
["2b. Score: The Bid Evaluation Committee will assign a score of 0 or 1 for each specification, which indicates the level of compliance, as follows:"]
["0 - The specification does not  comply.                                                                                                                                                                                                                                                                                  1 -  The specification is fully compliant."]
["2c. Weighted and Total Score: The score will be multiplied by the weight to give the total score for each specification and be added up. "]
["2d. The bidders must comply as follows with the specification: "]
["i. The bidders must comply with all the specifications (line items) with a # weight. "]
["ii. The bidders must obtain a minimum threshold score of 8 or higher out of 11 points in respect of specifications (line) with a weight of 1."]
["A","B","C","D","E","F"]
["Item no.","Product Specification","Weight","Comply (Yes/No)","Details of Product Offered (Provide your answers in this Column. You are advised to be straight to the point)","Reference to Brochure / Technical Data Sheet (verification)"]
[1,"GENERAL DESCRIPTION"]
["1.1","High dose rate remote afterloader brachytherapy unit.","#"]
[2," Compulsory Technical specifications"]
["2.1","A high dose rate remote afterloading unit using a single high activity radiation source for brachytherapy is required. ","#"]
["2.2","The afterloading unit shall be used for intra-cavitary, intraluminal, interstitial and intra-operative brachytherapy","#"]
["2.3"," The source positioning system of the afterloading unit accommodates the highest possible level of safety as per regulatory requirement.","#"]
["2.4","Successful testing according to ISO 2919:2012-08 or as accepted by SAHPRA.","#"]
["2.5","Compulsory Functional specifications:"]
["2.5.1","Capable of delivering high dose rate remote afterload treatment. The unit must be capable of performing multi channel variable dwell time brachytherapy. Vendor must indicate the number of channels that will be provided.","#"]
["2.6","Safety Features: "]
["2.6.1","Safety Features: The afterloader shall be permanently installed in a radiation shielded treatment room. The respondent shall specify the room shielding requirement for the afterloader offered. The room must be constructed to comply with these requirements.","#"]
["2.6.2","It must be possible to exchange sources remotely in the shielded treatment room.  The exposure to staff to ionizing radiation during the source exchange process shall be kept to a minimum and within the levels of radiation exposure satisfying the requirements of SAHPRA.","#"]
["2.6.3","The HDR treatment delivery system must have a \"check\" cable that automatically checks for a free and unobstructed pathway for the source to the most distal dwell position (of each and every programmed channel) immediately prior to treatment. There shall be a reliable means to clearly distinguish between the dummy and the active sources with full details provided by the respondent. It should also be possible to use the check cable as a \"Dummy\" source to allow simulation of possible source locations.","#"]
["2.6.4","The afterloader takes minimal space and is easily manoeuvrable around the patient within the treatment room","#"]
["2.6.5","A rechargeable battery back-up power source shall be incorporated in the Brachytherapy design to protect against a power failure.  The batteries shall be sufficient to maintain all systems for a period of at least one hour. Battery is under service maintenance contract","#"]
["2.6.6","The treatment unit shall also be designed so that, when the rechargeable battery power source has not adequately charged (or has completely failed altogether), a warning fault message or operational interlock shall occur","#"]
["2.6.7","The source must be automatically retracted in the event of any system or power failure. As a back up, an independent emergency drive system must also be incorporated in the system.","#"]
["2.6.8","Manual retraction of the radioactive source must be possible in an emergency situation and in the case of total power failure where automatic return of the radioactive source is not possible.","#"]
["2.6.9","The treatment time and source position must be continuously monitored so that a permanent record may be recovered after an interrupted treatment.  The method of monitoring and recording of all treatment must be specified.","#"]
["2.6.10","The brachytherapy system shall have a back-up timer in the case of failure of the primary timer that controls the treatment period of exposure. Both timers shall be capable of terminating the treatment at the set time, in the case of the primary timer, and at a specified time after the end of the set time, in the case of the back-up timer.","#"]
["2.6.11","An interlock system must be provided for a door interlock which, if the door is activated, automatically retracts the radioactive source back into the shielded safe.  The respondent must also supply a list of any other interlock options.","#"]
["2.6.12","The respondent must include an appropriate independent radiation monitor, which provides a clear indication of the radiation level in the treatment room. ","#"]
["2.6.13","The respondent must include audiovisual patient monitoring system that enables real-time observation of the patient, afterloader and auxiliary patient monitoring equipment. System should include two cameras with pan, tilt, zoom movements, all cameras displayed on one screen (> 20\") and the system shall be backed up by a UPS. ","#"]
["2.6.14","The system must ensure that treatment is inhibited and that the radioactive source does not leave the safe until the following has been established:\n  • all applicator connections have been verified;\n  • the path between the source housing and the distal end of the treatment volume is free of obstructions;\n  • it has been confirmed that all planned dwell positions can be reached\n  • the door is closed. ","#"]
["2.7","Quality assurance"]
[null,"System must come with a set of quality assurance tools:"]
["2.7.1","Standard accessories necessary for the complete and proper functioning of the equipment.","#"]
["2.7.2","The HDR system must have an adequate range of QA accessories.  A full list of accessories available with the system must be provided by the respondent. ","#"]
["2.7.3","Clinical QA devices: In vivo dosimetry for real time patient monitoring (bladder and rectal doses) must be included.",1]
["2.7.4","Standard absolute dosimetry calibration kit with source specific well-type ionisation chamber, source insert, electrometer, thermometer and barometer.","#"]
["2.7.5","Check source ruler for daily source position check, with transfer tube.","#"]
["2.7.6","Two Boxes of EBT 3 films for Autoradiography ",1]
["2.7.7","Survey meter with external Geiger -Mueller counter.",1]
["2.7.8","Laptop with recent software for Calibration of source activity (Microsoft office and Invivo dosimetry). Laptop must have capability of running software. Minimum 17 in screen with appropriate hardware and software.  Hardware and software must be updated over period of maintenance.","#"]
["2.8","Treatment control system"]
["2.8.1","The Treatment Control System must be capable of plan transfer via a network connection.  Details and any alternative methods of plan transfer shall be provided by the respondent.","#"]
["2.8.2","The Treatment Control System must be capable of plan transfer via a network connection.  Describe how it is ensured that the latest version of the plan is used.","#"]
["2.8.3","The Treatment Control System must allow storage of multiple standard plans, keep track of a patient's fractionated treatment, allow easy editing of treatments [protected by password for authorized users] and act as a treatment verification computer.","#"]
["2.8.4","Two dimensional  and three dimensional CT/MRI compatible treatment planning system with all IT requirements to ensure compatibility and functionality with DICOM compatibility.","#"]
["2.8.5","Operation of the system should be protected by key and individual passwords for each operator, to prevent operation by unauthorized users.","#"]
["2.8.6","Treatment plans and images must be stored on a server/cloud system. Server and cloud must be of adequate speed and capability to store data generated","#"]
["2.8.7","Server based image import/export system-allows connectivity between CT/MRI simulator and HDR planning unit or any other diagnostic unit at all times.","#"]
["2.9","Remote operating console"]
["2.9.1","The remote operator console shall clearly indicate whether:\n   • the source is in, out or in transit from the storage shield; and\n   • machine status.","#"]
["2.9.2","Any treatment unit operational faults shall be clearly and unambiguously displayed at the remote control. A visual and acoustic alarm shall be activated when a major fault occurs.","#"]
["2.9.3","The remote operator console shall clearly indicate whether:\n   • the source is in, out or in transit from the storage shield; and\n   • machine status.","#"]
["2.9.4","Any treatment unit operational faults shall be clearly and unambiguously displayed at the remote control. A visual and acoustic alarm shall be activated when a major fault occurs.","#"]
["2.9.5","Access to critical data must be password protected and limited to authorized users. It should also be possible to create several levels of authorization.","#"]
["2.9.6","Warnings must be given in plain text with clear indication of actions to be taken.","#"]
["2.9.7","The Treatment Control System should act as a treatment verification device with the Treatment Control System controlling the treatment. ","#"]
["2.9.8","The treatment times must be automatically corrected for the decay of the radioactive source.  The respondent shall provide details.","#"]
["2.9.9","A UPS must be included to maintain treatment data, operation of the treatment control system and afterloader in case of external power failure.   If a power failure takes place, there should be some means (e.g. a printer) to automatically record all patient treatment data, source configurations and times. Please provide details of the recording device. \n","#"]
["2.9.10","In the event of external mains failure, after power is re-established it should be possible to resume treatment, following user acknowledgment, at the exact dwell position where treatment was interrupted, with the remaining dwell time accurate to within 0.1 second.","#"]
["2.9.11","The display unit must show step position and the corresponding dwell time to 0.1 second accuracy.","#"]
["2.9.12","The Control System should include a hard copy feature to allow a printout of treatment data including step size, dwell position, treatment dwell time and in particular the information about the patient. It must also be possible to print out standard plans and the history logbook mentioned above. The Respondent shall provide an example of a treatment report. Printer must be provided.","#"]
["2.9.13","It must be possible to manually program a treatment. With the correct authorization it must also be possible to edit a treatment.","#"]
["2.9.14","A protection circuit must be included to prevent treatment without the treatment applicators being correctly connected.",1]
[3,"Radiation source and source  transfer mechanism"]
["3.1","Source:"]
["3.1.1","The  source shall have a typical predefined nominal activity.  The exact activity of each source shall be certified by the Respondent with full details of its specifications including accuracy of the calibration.  Any limitations in the certification of the radioactive source must be stated.",1]
["3.1.2","The physical source dimensions should be as small as possible but shall be no greater than:\n   • 5mm active length;\n   • 5mm total length; and\n   • 0.9mm external diameter.",1]
["3.1.3","The source cable combination must be tested and certified to withstand a minimum of 5,000 transfers per source.",1]
["3.1.4","Source must be suitable for insertion into interstitial needles, which are 17 gauge or smaller.",1]
["3.1.5","The source/cable design must be such that it will not perforate treatment catheters.",1]
["3.1.6","The respondent shall provide details of any other isotopes/sources available for use with the afterloading unit. ",1]
["3.2","Source position accuracy"]
["3.2.1","The afterloading system must meet source position accuracy of ± 1 mm (This refers to the absolute position of the source in the applicator and not just step accuracy).","#"]
["3.2.2","To establish the expected position of the radioactive source, a radiation opaque, non-active dummy source(s) shall be available to use to indicate the active source positions.  The Respondent shall provide details of the non-active dummy source operation.",1]
["3.2.3","Sources must be stepped in a manner that ensures the uncertainty due to \"backlash\" is less than 0.5 mm.","#"]
["3.3","Source installation"]
["3.3.1","The maximum time period and the maximum number of source transfers between source changes shall be specified.","#"]
["3.3.2","Sources shall be replaced at intervals determined by the half life or activity, or earlier should the maximum number of source transfers be exceeded in that period, until the contract of supply is terminated in writing by the Contractor or the Hospital.  The cancellation of the supply of a radioactive source contract by either party shall require ninety (90) days notice. Cancellation by the Contractor shall also be subject to the Contractor providing a suitable alternative supplier of source/material compatible with the Brachytherapy unit purchased under this Request.","#"]
["3.3.3","The total system including radioactive sources shall have current authorization for import into this country from its country of origin. The respondent will be responsible for delivery of all equipment including radioactive sources to the Department of Radiation Oncology.","#"]
["3.3.4","In the event that the maximum number of source transfers is about to be exceeded, the respondent shall guarantee the delivery of a replacement source with appropriate maximal activity  within ten (10) working days of the Respondent receiving notice.","#"]
["3.3.5","The respondent shall provide full details on:\n   • the radioactive source manufacturer(s);\n   • the reliability of source delivery dates; and\n   • the method and time schedule of the source deliveries.","#"]
["3.3.6","The respondent must provide source replacement for the period of maintenance","#"]
["3.3.7","The source change procedure must be performed in a safe and expedient manner. During source change, the manufacturer's engineer must also perform preventative maintenance and inspection (PMI). The respondent shall indicate time required for source exchange and PMI.","#"]
["3.3.8","The respondent should submit a list of the ten (10) most recent source exchanges performed, listing the site, contact name, intended date of installation, actual date of installation, and the installed source activity.","#"]
["3.3.9","The system must use a drive cable to assure necessary strength and flexibility. A diameter of the cable will be specified, where 0.9 millimetres is the maximum allowed.","#"]
["3.4","Accuracy"]
["3.4.1","State the type of source drive mechanism.","#"]
["3.4.2","A feedback circuit to assure precise source positioning is required. The system should be able to detect and respond to source movement during the dwell period.","#"]
[4,"Unit shall comprise "]
["4.1","Treatment console and planning area","#"]
["4.2","Treatment delivery area ","#"]
["4.3","Operating room area: including clinician wash area and theatre space for insertion of applicators. ","#"]
["4.4","Patient waiting area","#"]
["4.5","WC and sluice area","#"]
["4.6","Patient recovery area","#"]
["4.7","Rooms should be adapted for brachytherapy purposes","#"]
["4.8","Lighting"]
["4.8.1","Specialised theatre lights (LED) must be installed in designated spaces including treatment room and theatre designated for insertion of applicators","#"]
[5,"Treatment bed"]
["5.1","A special bed designed for patient positioning and transfer for brachytherapy. The bed must allow leg support in lithotomy, patient transfer to and from CT and MRI scanner. Bed table must interchangeable for CT and MRI use. Electronic operational mechanism with over ride feature enabling movement in different axes. Bed must allow for applicator clamping, IV bag positioning and head  support framework","#"]
["Total Weighted score",null,11]

{"sheet":"Treatment Planning System","index":1,"n_rows":79,"n_cols":6,"rows_kept":79,"merged":[[0,0,0,5],[1,0,1,5],[2,0,2,5],[3,0,3,5],[4,0,4,5],[5,0,5,5],[6,0,6,5],[7,0,7,5],[8,0,8,5],[9,0,9,5],[10,0,10,5],[11,0,11,5],[12,0,12,5]]}
["THE SUPPLY, DELIVERY, INSTALLATION, COMMISSIONING AND MAINTENANCE OF  HIGH DOSE RATE (HDR) BRACHYTHERAPY UNIT AT GAUTENG HEALTH INSTITUTIONS FOR A PERIOD ON THREE YEARS"]
["Note:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   "]
["1. Technical Compliance"]
["All equipment tendered for must be technically compliant to qualify for consideration for the next phase of evaluation"]
["2. Scoring of the bids"]
["2a. Weight: Each specification will have a weight of 1 or a hash (#), which indicates the level of importance, as follows:   "]
["1 -  A specification with a standard level of importance that must be complied with.,"]
["# -  Indicates a specification with a essential level of importance, where the bid offer will be disqualified, if the specification is not complied with."]
["2b. Score: The Bid Evaluation Committee will assign a score of 0 or1 for each specification, which indicates the level of compliance, as follows:"]
["0 -  The specification does not  comply.                                                                                                                                                                                                                                                                             1 -  The specification is fully compliant."]
["2c. Weighted and Total Score: The score will be multiplied by the weight to give the total score for each specification and be added up. "]
["2d. The bidders must comply as follows with the specification: "]
["i. The bidders must comply with all the specifications (line items) with a # weight. "]
["A","B","C","D","E","F"]
["Item no.","Product Specification","Weight","Comply (Yes/No)","Details of Product Offered (Provide your answers in this Column). You are advised to be straight to the point)","Reference to Brochure / Technical Data Sheet (verification)"]
[1,"Algorithm"]
["1.1","Brachytherapy calculations: include inverse square corrections for point sources, point and line source calculations, tissue correction factor . CT, MRI, PET and ultrasound data entry capabilities. ","#"]
["1.2","Dosimetry Algorithm based on TG 43/equivalent European","#"]
[2,"Applicator Modelling"]
["2.1","Applicators must be stored into the system for quick and easy applicator reconstruction","#"]
["2.2","Visualization and planning of shielded applicators should be easily achievable","#"]
[3,"Connectivity"]
["3.1","Connectivity - afterloader","#"]
["3.1.1","Treatment planning System should be integrated with the HDR machine.","#"]
["3.2","Connectivity - Dicom","#"]
["3.2.1","Treatment Planning System should be networked with the  CT Scanner and/or MRI present in the institute.","#"]
[4,"Contouring"]
["4.1","Spyglass tool should be available for contouring on fused images.","#"]
["4.2","Dosimetry "]
["4.2.1","What drawing tools for contouring are available? Please give a description of the available tools.  Indicate any particular unique attributes of your contouring features.","#"]
["4.2.2","Automatically define dose constraint lines with fixed constant distance from a catheter or applicator structure","#"]
["4.2.3","Based on a default step value, define with the mouse the treatment length within a catheter and automatically assign the dwell positions required","#"]
["4.2.4","Define single dose constraint points or lines","#"]
["4.2.5","Determine time required to give desired dose at prescription points","#"]
["4.2.6","The dose grid matrix size in two and three dimensional planes must be described","#"]
["4.3","Dose volume histogram: DVH"]
["4.3.1","Can the user specify if the displayed DVH is in- or excluding the volume of the applicators?","#"]
["4.4","Evaluation"]
["4.4.1","Tools for plan evaluation, reviewing and analysing to perform comparison, summary and subtraction of plans, doses and dose volume histograms should be available.","#"]
["4.5","External beam"]
["4.5.1","Wide range of dose volume histogram methods, Point dose option, Different planes view must be available.","#"]
["4.6","General"]
["4.6.1","Teletherapy software module for conventional 3D treatment planning for summation of teletherapy & brachytherapy should be provided along with plan evaluation tools.","#"]
[5,"Connectivity DICOM"]
["5.1","A dedicated brachytherapy treatment planning system shall be offered to calculate 2D and 3D dose distributions and source dwell times based on 3D anatomical images imported from various imaging modalities","#"]
["5.2","General"]
["5.2.1","Data file formats shall be provided including description of file contents for treatment plan dose distribution files, patient information / contour files and plan evaluation data","#"]
["5.2.2","Display of 3D organs, isodose curve and overlay on CT images shall be provided.","#"]
["5.2.3","Modify Window sizes","#"]
["5.2.4","Operation of the System should be simple and interactive by way of a simple menu","#"]
["5.2.5","Software must allow display of brachytherapy dose distributions, using different display options","#"]
["5.2.6","The planning system should be capable of displaying dose distributions using 3D colour graphic displays as standard","#"]
["5.2.7","The respondent shall state the length of time expected to complete the total planning process for a typical 18 needle prostate implant using CT images","#"]
["5.2.8","The software shall be written to allow for multi-tasking through a multiple windowing environment","#"]
["5.2.9","TPS has 3D brachytherapy software and supports all of the brachytherapy treatment modalities including Intracavitary, Interstitial, Intraluminal as well as Surface mould techniques.  Please describe.","#"]
[6,"Hardware","#"]
["6.1","User selectable isodose levels and colours, including solid rendering or colour wash","#"]
["6.2","19” TFT screen – Flat panel display","#"]
["6.3","A3 flatbed scanner with good resolution has to be provided.","#"]
["6.4","Console computer system  -  must be compatible with hospital network","#"]
["6.5","Describe the treatment planning computer specifications.  Laser printer included","#"]
["6.6","Details of the offered Planning System's computer system shall be specified. The computer central processor, memory, disk capacity, digitizer and/or film scanner, a high resolution tablet  monitor (minimum 19 inch), a colour duplex laser printer and any other peripheral devices necessary for the system to be operated as intended.","#"]
["6.7","HOST COMPUTER SYSTEM – Specify the storage capacity of the planning software system, backup and clean-up procedures required.","#"]
["6.8","The graphics card and screen resolution 1600 x 1280","#"]
[7,"Image Fusion/Registration"]
["7.1","The planning system workstation should be powerful with multi-processing capability and large processing memory to perform planning (calculations) in a fast manner. Sufficient storage capacity shall be provided in addition to standard CD/ DVD multi-function drives. Provide full hardware specifications.","#"]
["7.2","CT/MR Image Fusion","#"]
["7.3","Image fusion capability, allowing any 3D data set to be aligned with any other 3D data set, including blended views for image review","#"]
["7.4","It should be possible to do multimodality image registration (fusion) using CT, MR and PET, PET CT data sets. ","#"]
["7.5","Image handling"]
["7.5.1","The software shall have the ability to generate digitally reconstructed radiographs (DRRs) from CT data for verification of catheter reconstruction and comparison with AP and lateral check films","#"]
[8,"IT"]
["8.1","Tools to measure:\n-distance\n- angles\n- dose at a point\n- dose profile","#"]
["8.2"," Antivirus programme","#"]
["8.3","All required networking works to connect different components together and to the hospital network should be included.","#"]
["8.4","Source data entry change protection ","#"]
["8.5","It is the responsibility of the respondent to fully acquaint themselves with the Radiation Oncology Department’s existing IT networks configuration including, hardware, software applications and functionality. The respondent must ensure full functionality with all clients and applications on the network","#"]
["8.6","Network requirements  – minimum of 1 gigabit per second network speed is required. The network shall be segmented from the rest of network.","#"]
["8.7","Networking capabilities must be provided. The respondent must confirm that the planning system is capable of being included in an industry standard computer network by the addition of standard network software add-ons. Any limitations or difficulties in this feature shall be disclosed here","#"]

{"sheet":"Applicators","index":2,"n_rows":60,"n_cols":6,"rows_kept":60,"merged":[[0,0,0,5],[1,0,1,5],[2,0,2,5],[3,0,3,5],[4,0,4,5],[5,0,5,5],[6,0,6,5],[7,0,7,5],[8,0,8,5],[9,0,9,5],[10,0,10,5],[11,0,11,5],[12,0,12,5]]}
["THE SUPPLY, DELIVERY, INSTALLATION, COMMISSIONING AND MAINTENANCE OF  HIGH DOSE RATE (HDR) BRACHYTHERAPY UNIT AT GAUTENG HEALTH INSTITUTIONS FOR A PERIOD ON THREE YEARS"]
["Note:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   "]
["1. Technical Compliance"]
["All equipment tendered for must be technically compliant to qualify for consideration for the next phase of evaluation"]
["2. Scoring of the bids"]
["2a. Weight: Each specification will have a weight of 1 or a hash (#), which indicates the level of importance, as follows:   "]
["1 -  A specification with a standard level of importance that must be complied with.,"]
["# -  Indicates a specification with a essential level of importance, where the bid offer will be disqualified, if the specification is not complied with."]
["2b. Score: The Bid Evaluation Committe will assign a score of 0 or1 for each specification, which indicates the level of compliance, as follows:"]
["0 -  The specification does not  comply.     1 -  The specification is fully compliant."]
["2c. Weighted and Total Score: The score will be multiplied by the weight to give the total score for each specification and be added up. "]
["2d. The bidders must comply as follows with the specification: "]
["i. The bidders must comply with all the specifications (line items) with a # weight. "]
["A","B","C","D","E","F"]
["Item no.","Product Specification","Weight","Comply (Yes/No)","Details of Product Offered (Provide your answers in this Column. You are advised to be straight to the point)","Reference to Brochure / Technical Data Sheet (verification)"]
[1,"Gynaecological Applicators: There are 3 levels of applicator requirements 1. Applicators  for 2 Dimensional imaging (Fluroscopic image based) based brachytherapy. 2.Applicators for  volumebased with at least CT imaging compatibility and 3. Interstitial brachytherapy with MRI compatibility. Please refer to special conditions in separate document","#"]
["1.1","Intracavitatory applicators"]
["1.1.1","Basic level: Steel/Titanium Flourscopic and CT compatible"]
["1.1.1.1","Ring type and intrauterine applicator: Varying size rings, IU applicators. Must include rectal retractor, applicator clamping device, and fixation accessories.","#"]
["1.1.1.2","Manchester type applicator: Comprising shielded,ovoid applicators of varying sizes, IU tubes of varying sizes and angulations, rectal retractors, clamping devices, fixation straps","#"]
["1.1.2","CT compatible for volume based planning"]
["1.1.2.1","Ring type and intrauterine applicator: Varying size rings, IU applicators. Must include rectal retractor, applicator clamping device, and fixation accessories.","#"]
["1.1.2.2","Manchester type applicator/equivalent: Comprising shielded,ovoid applicators of varying sizes, IU tubes of varying sizes and angulations, rectal retractors, clamping devices, fixation straps","#"]
["1.1.2.3","Miami style applicator/equivalent for vagina, vaginal cuff cervix and cervical stump,endometrium with varying tandem lengths, tandem angles,  build up caps and required accessories","#"]
["1.1.2.4","Miami style/equivlaent multi-channel applicator for vaginal, vaginal cuff and endometrial cancer with varying tandem lengths, bulid up caps and fixation device","#"]
["1.1.2.5","Vaginal/Stump applictor: Rectum, endometrium ,vagina: varying lengths and cylinder diameter and perineal bar. Segmented and unsegmented applicator varities","#"]
["1.1.2.6","Endometrial Rotte type applicator: varying sizes","#"]
["1.1.3","Interstitial brachytherapy:                                                                                    This will be for implant based, MRI guided, adaptive brachytherapy.  "]
["1.1.3.1","Supplier must stipulate if applicators have limited durability. If so, supplier must replacement requirements ito years/number of cycles per applicator. Provision must be made for replacement over the 7 year contract period","#"]
["1.1.3.2","Interstitial brachytherapy applicators of various sizes:MR safe interstitial ring applicator set for treatment of the cervical area with possibility to reach parametrium , and an treat tumor stages III and/or IV  shall be provided. Varying ring sizes and intra-uterine tandem lengths","#"]
["1.1.3.3","Required Accessories including fixation devices, perineal plates, needles, cleaning accessories should be included.Tools for controlled needle insertion in interstitial gynecological applications","#"]
["1.1.3.4","Interstitial brachytherapy applicators of various sizes: MR safe interstitial ovoid and ring applicator set for treatment of the cervical area with possibility to reach parametrium , and  treat tumor stages III and/or IV  shall be provided. Varying ovoid sizes and intra-uterine tandem lengths","#"]
["2.","Prostate Brachytherapy: Designed for CT and ultrasound based planning techniques. "]
["2.1","Ultrasound based system must be capable of providing real time prostate brachytherapy","#"]
["2.2","Applicator sets are to be provided for prostate HDR applications. Supplier should indicate must provide list of re-usable and un re-useable applicators","#"]
["2.3","Software: Prostate plannig software and database software. Upgrades over service period to be included","#"]
["2.4","Hardware"]
["2.4.1","Stepper with ultrasound probe and template capable of interconnecting with treatment planning system","#"]
["2.4.2","Pernieal template system capable of securing applicators to the system","#"]
["2.4.3","Laptop station with docking station and monitor","#"]
["2.4.4","Computer‑controlled, motor‑driven rotational device used to rotate the ultrasound probe  needed for rotational probe/stepper systems.","#"]
[3,"Oesophageal"]
["3.1","Applicator sets are to be provided for esophagus","#"]
["3.2","A reusable applicator set for esophagus with dilation capacity shall be provided. The diameter range and sterilization method shall be specified.","#"]
["3.3","Mentioned esophageal applicators shall be suitable for sterilization","#"]
["3.4","Required accessories to be included","#"]
[4,"Head and neck"]
["4.1","Applicator sets are to be provided for head & neck","#"]
["4.2","An Intracavitary applicator for nasal treatment is to be provided","#"]
["4.3","Required accessories to be included","#"]
[5,"Skin"]
["5.1","Applicator sets are to be provided for skin & surface applications","#"]
["5.2","Applicator sets are to be provided for facial applications, to reduce the radiation leakage to approximately 10% @ a distance of 10 mm","#"]
[6,"Miscallaneous"]
["6.1","Rigid stainless steel needles shall be provided, CT and MR compatible. Please provide details on materials used, sizes and type of needle point.  ","#"]
["6.2","Titanium needles shall be provided, CT and MR compatible. Please provide details on materials used, sizes and type of needle point.  ","#"]
["6.3","MR safe plastic needles shall be provided. Please provide details on materials used, sizes and type of needle point.  ","#"]
["6.4","Smit sleeve:varying lenghts","#"]
["6.5","Patient positioning and transfer system for brachytherapy: Bed must have electronic lift mechanism (X,Y,Z positions) and support large body mass index patient.Bed must have CT and MRI compatibile couches to allow transfer for imaging. Applicator fixation and lithotomy positioning accessories must be included.","#"]
["6.6","Overhead theatre LED lighting in areas designated for applicator insertion","#"]